Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Madsbad S – The long–acting once–daily human GLP–1 receptor agonist liraglutide reduces HbA1c by about 1.0–2.0% point, weight by 1–3kg and seems to have fewer gastrointestinal side effects than exenatide. The final place of the GLP–1 receptor agonists in the diabetes treatment algorithm will be clarified when we have long–term trials with cardiovascular end–points and data illustrating the effects on the progression of type 2 diabetes.

Today in Pharmacology/kinetics...keeping you current

The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/04/09

Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/04/09

Myxedema Coma Associated with Combination Aripiprazole and Sertraline Therapy
Annals of Pharmacotherapy, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address